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Autoimmune diseases occur more often in females, suggesting a key role for the X
chromosome. X chromosome inactivation, a major epigenetic feature in female cells that
provides dosage compensation of X-linked genes to avoid overexpression, presents special
vulnerabilities that can contribute to the disease process. Disruption of X inactivation can
result in loss of dosage compensationwith expression from previously sequestered genes,
imbalance of gene products, and altered endogenous material out of normal epigenetic
context. In addition, the human X has signiﬁcant differences compared to other species
and these differences can contribute to the frequency and intensity of the autoimmune
disease in humans as well as the types of autoantigens encountered. Here a link is
demonstrated between autoimmune diseases, such as systemic lupus erythematosus,
and the X chromosome by discussing cases in which typically non-autoimmune disorders
complicated with X chromosome abnormalities also present lupus-like symptoms. The
discussion is then extended to the reported spatial and temporal associations of the
inactive X chromosome with the nucleolus. When frequent episodes of cellular stress
occur, the inactive X chromosome may be disrupted and inadvertently become involved
in the nucleolar stress response. Development of autoantigens, many of which are at
least transiently components of the nucleolus, is then described. Polyamines, which aid
in nucleoprotein complex assembly in the nucleolus, increase further during cell stress,
and appear to have an important role in the autoimmune disease process. Autoantigenic
endogenous material can potentially be stabilized by polyamines. This presents a new
paradigm for autoimmune diseases: that many are antigen-driven and the autoantigens
originate from altered endogenous material due to episodes of cellular stress that disrupt
epigenetic control. This suggests that epigenetics and the X chromosome are important
aspects of autoimmune diseases.
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INTRODUCTION – EPIGENETICS AS CHROMATIN DYNAMICS
Epigenetics is the area of biology that connects environmental
factors with gene expression patterns in cells. We are still discov-
ering new aspects of epigenetics so a detailed and comprehensive
deﬁnition of epigenetics is still developing (Bird, 2007; Berger
et al., 2009). There is complexity to epigenetics and its dynam-
ics since the scope of epigenetics ranges physically from individual
DNA base pairs (bp) to chromosomes and ranges temporally from
individual steps of the cell cycle in somatic cells to generational
inheritance of gene expression patterns from parent to child. As
a general deﬁnition we can consider epigenetics to be a means by
which expression levels of genes and the resulting RNA and pro-
tein levels originating from the genes, can be controlled without
alteration of the DNA sequence of the gene. Epigenetic regula-
tion of gene expression includes heritable and reversible DNA
modiﬁcations, modiﬁcations of DNA-binding proteins, such as
histones, and generation of microRNAs (miRNAs) that interact
with messenger RNAs (mRNAs) leading to degradation of the
mRNA thereby suppressing gene products (Chuang and Jones,
2007). And we need to consider epigenetics as dynamic since
gene expression patterns under epigenetic control can change in
development, differentiation, and in response to cellular stress.
The DNA methylation status in chromatin is a key feature in
epigenetic control.Methylationof carbon5 in cytosine rings (5mC)
in eukaryotes, particularly in promoter regions of genes, is asso-
ciated with suppression of gene expression since the 5mC alters
protein binding sites and recruits additional chromatin modifying
factors, such as histone deacetylases. This control is supported by
binding of proteins, such as the DNA methyl binding protein 2
(MECP2), which add another layer of control, supporting sup-
pression or activation depending on the transcriptional context of
the underlying genes. In the case of MECP2, it can bind both 5mC
and 5-hydroxymethylcytosine (5hmC). However, DNA methyla-
tion can be reversed by a stepwise process that involves the recently
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discovered conversion of 5mC to 5hmC, followed by conversion to
unmethylated cytosine. This process, 5mC to 5hmC to cytosine,
is not yet fully understood but reversal of DNA methylation can
potentially lead to changes in the expression of the underlying
genes (Pfeifer et al., 2013).
Another important feature of epigenetic control is the pack-
aging and compaction of DNA by histones. The basic unit of
chromatin is the nucleosome which consists of approximately
145 bp of DNA wrapped around an octameric core of his-
tones. Most DNA is associated with nucleosomes which occur
on average approximately every 200 bp in humans. The cationic
charges of arginine and lysine residues in the histones counter
the self-repulsion of the anionic DNA allowing for compaction
of the chromatin, making the underlying gene less accessible.
However, post-translational modiﬁcation of histones, such as
acetylation or methylation of arginine residues in the histone, can
reduce cationic charges on the histones and loosen the histone-
DNA interactions in the nucleosome, contributing toward greater
access to the underlying gene. These epigenetic modiﬁcations
are reversible which can then contribute toward histone–DNA
interactions that alter accessibility to the underlying gene. In
addition, subnucleosomal complexes, such as histone hexamers
bound to DNA, asymmetric histone modiﬁcations in the nucle-
osome, and histone subtypes give even more variation in the
accessibility and control of genes (Rhee et al., 2014). The nucle-
osomes and DNA can appear as “beads on a string” when the
chromatin is most accessible, which is referred to as euchro-
matin. Euchromatin is considered to be areas of chromatin that are
transcriptionally active or at least potentiated for activity. When
the nucleosomes are stacked together facilitated by histone H1
which binds to the linker DNA between nucleosomes, the DNA is
less accessible, and appears to be predominantly inactive. This
dense packing of the DNA and nucleosomes is referred to as
heterochromatin.
Another group of factors in epigenetics is the miRNAs (Ha
and Kim, 2014). miRNAs serve as post-transcriptional regula-
tors of an estimated one-third of mRNAs. miRNAs are known
to be involved in regulating apoptosis, cellular differentiation, cell
cycling, and immune functions (Pauley et al., 2009). miRNAs are
ﬁrst transcribed by RNA polymerase II yielding primary miR-
NAs (pri-miRNAs; Lee et al., 2004). The pri-miRNA is processed
by Drosha and Dicer in the nucleus to yield an approximately
70 base precursor miRNA (pre-miRNA) which is exported to
the cytoplasm (Denli et al., 2004). Dicer then cleaves the pre-
miRNA to a miRNA of 19–25 bases, which is loaded into the
RNA-induced silencing complex (RISC). This complex can bind
the target mRNAs and facilitate degradation of the mRNA, post-
transcriptionally suppressing the gene expression (Ceribelli et al.,
2011). Multiple miRNAs can target a speciﬁc mRNA and some
individual miRNAs can target multiple mRNAs.
Long non-coding RNAs (lncRNAs), which can be 100s–1000s
of bases in length, also have roles in epigenetic control.
The lncRNAs can suppress transcription frommultiple genes. The
X-inactivation speciﬁc transcript (XIST) is an example of the lncR-
NAs. XIST RNA is involved in the silencing of one of the two X
chromosomes in female cells. Since most X-linked genes are used
at equivalent levels in both male and female cells, only one X
chromosome is needed. Early in embryonic development each
human female cell randomly chooses one of its two X chromo-
somes to be inactivated, leaving only one active X chromosome.
This establishes X-linked gene dosage compensation such that
female and male cells have equivalent expression and product
levels for most X-linked genes. The X chromosome selected for
inactivation expresses multiple copies of XIST which bind to con-
tiguous chromatin along the X chromosome and recruit other
epigenetic suppressing factors, such as DNA methyltransferases
(DNMTs). X inactivation results from synergy of XIST RNA,DNA
methylation, histone deacetylation as well as many other factors
(Csankovszki et al., 2001). The result is that 75–85% of genes on
the inactive X chromosome are silenced or have reduced expres-
sion relative to the active X chromosome (Carrel and Willard,
2005; Cotton et al., 2013). The X-linked genes that show vari-
able escape or reactivation from X inactivation, approximately
5% of genes on the long arm Xq and 35% on the short arm,
Xp, are more often located close to or even between genes that
are normally expressed from both the active and inactive X chro-
mosomes, such as genes at Xp22.1 on the short arm (Carrel and
Willard, 1999; Carrel et al., 1999). Daughter cells will inherit the
same X inactivation patterns although there can be infrequent
reactivation of some genes on the inactive X with age (Ware-
ham et al., 1987), during some stages of development (Ohhata
and Wutz, 2013), or as a result of chemical insult, such as with
the demethylating agent 5-azacytidine (Venolia et al., 1982). The
genes that escape from X inactivation can vary among cell lines
and tissue types (Carrel and Willard, 2005). The possibility of
reactivation of X-linked genes in somatic cells is an area of cur-
rent interest since it may have an underlying role in some disease
mechanisms. Duplication and/or reactivation of X-linked genes
and even X chromosomes has been reported in some tumors
and is infrequently observed in cell cultures (Ohhata and Wutz,
2013). We should note that: (1) most studies on X inactivation
and X-linked gene reactivation from the inactive X chromosome
are performed with mouse cells or human-mouse hybrid cells;
(2) the mouse X chromosome has proven to be problematic
in these studies since the mouse X chromosome is very robust
in absorbing experimental chemical insults applied to study the
stepwise reactivation of individual genes of the inactive X, i.e.,
partial reactivation of the inactive X; (3) these studies monitor
protein coding genes transcribed by RNA polymerase II (RNA
pol II) whereas non-coding X-linked genes and elements tran-
scribed by X-linked RNA polymerase III (RNA pol III) may be
more informative, as discussed below, since their transcriptional
activation is not as complicated as that of RNA pol II transcribed
genes.
We can view epigenetics as a dynamic process since the
reversible nature of epigenetic control allows for changes that
can open silenced genes to become potentially active genes and
back. And it can convert large regions of chromatin from euchro-
matin to heterochromatin and back. A recent report describes
the three-dimensional arrangement of the human genome at a
resolution of 1 kb (Rao et al., 2014). The authors reported that
the human genome structure has approximately 10,000 chromatin
loops most of which were less than 2 mb with the majority of the
loops anchored by the transcriptional regulator CCCTC-binding
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factor (CTCF). These loops can provide more accessibility to the
genes in the loop and allow for dynamic inter-loop associations
of genes bringing them into a shared context. The authors also
reported interesting observations on the inactive X chromosome
structure, that it had two major domains and it had six super
loops, four of which were associated with the sites of lncRNA
genes (DXZ4, XIST, loc550643, and FIRRE). Each of these lncR-
NAs may have a role in maintenance of the X inactivation state in
their vicinity. The two domains observed in the inactive X chro-
mosome lay on either side of the DXZ4 gene, which is in the
middle of the X long arm, Xq (Chadwick, 2008). These domains
and lncRNAs suggest bipartite, even multipartite aspects to the
epigenetic control of the genes and regions of the inactive X
chromosome.
The involvement of epigenetics in autoimmune disorders has
become a topic of increasing interest as reports accumulate of
epigenetic dysregulation associated with speciﬁc autoimmune dis-
orders (Brooks et al., 2010; Thabet et al., 2013; Konsta et al., 2014).
Epigenetic dysregulation due to methylation/demethylation has
been reported in regards to speciﬁc genes and autoimmune dis-
orders, such as inability in some lupus patient B lymphocytes
to methylate the promoter of the human endogenous retrovirus
(HERV) gene, HRES1/p28, leading to its overexpression in lupus
(Fali et al., 2014). Another example is the expression of the CD5
protein in B lymphocytes. CD5 is a cell surface protein involved
in intracellular signaling to suppress autoreactivity. In some lupus
patients, an alternative promoter becomes demethylated leading
to a switch from the CD5-E1A isoform normally found at the
cell surface to the CD5-E1B isoform that is retained in the cyto-
plasm resulting in a failure to suppress autoreactivity (Garaud
et al., 2009).
In reality, epigenetics ismore than just themethylation state and
accessibility of speciﬁc genes. Higher levels of epigenetic control
mechanisms, such as X inactivation, can affect entire chromo-
somes containing a diverse collection of genes. Epigenetics also
involves spatial relationships of genes that are brought into close
proximity for a common purpose (e.g., genes for enzymes in a
common pathway) so that their expression can be more efﬁciently
regulated. Epigenetic suppression and compacting of chromatin
also stores potential DNA supercoiling stress that, when released,
can disrupt and alter chromatin over hundreds even thousands
of bps, rapidly unraveling heterochromatin into more accessi-
ble extended loops. Each nucleosome stores supercoiling stress
that, when released, can ﬂux through the chromatin causing twist-
ing and disruption of the chromatin structure as the chromatin
adjusts to accommodate the stress (Brooks, 2013). The released
supercoiling stress can also allow the transient appearance of alter-
nate DNA conformations which can mask protein binding sites
and slow repair and replication of DNA. In this manner we can
envision potential temporal effects in cells, such as delays in S
phase replication of some chromatin when there is epigenetic
dysregulation. In the extreme, there could be loss of genes and
disproportionate inheritance of genetic material by daughter cells
with epigenetic dysregulation. Thus, epigenetic control must be
maintained even during cellular stress. We can think of epigenetics
as the dynamics of chromatin that occurs atmany levels from short
stretches of DNA capable of ﬂipping to alternate conformations,
to nucleosomes, to loops of hundreds of nucleosomes, to entire
chromosomes. And we should think of the spatial and temporal
effects of epigenetics since epigenetic changes can alter the tim-
ing and success of chromatin replication, repair, and daughter cell
inheritance.
THE FEMALE PREDOMINANCE OF AUTOIMMUNE DISEASES
Autoimmune diseases are estimated to affect 5–10% of the pop-
ulation with the majority of autoimmune disease patients being
female. However, the female:male ratio differs among the diseases.
For example, the ratio is only slightly above 1:1 in inﬂammatory
bowel disease and diabetes mellitus type 1, whereas the ratio is
approximately 2:1 in multiple sclerosis (MS), 3:1 in rheumatoid
arthritis (RA), and 9:1 to 10:1 in systemic lupus erythemato-
sus (SLE), Sjögren’s syndrome (SjS) and autoimmune thyroiditis
(Invernizzi et al., 2009). This overall female predominance sug-
gests possible involvement of the X chromosome. Since females
normally have two X chromosomes (Figure 1A) in each cell while
male cells have only oneX chromosome (Figure 1B), this suspicion
of the X is supported by the observed rates of SLE in Klinefelter’s
syndrome in which (47, XXY) males with an extra X chromosome
have a rate of SLE 14x greater than (46, XY) males (Figure 1D;
Scoﬁeld et al., 2008; Sawalha et al., 2009). On the other hand, the
relationship between the X chromosome and autoimmune dis-
eases appears to be more nuanced when one considers Turner’s
syndrome and autoimmune diseases. Turner’s syndrome is typi-
cally thought of as an X monosomy (45, XO) female (Figure 1C).
Previously it was thought that rates of autoimmune diseases in
Turner’s syndrome patients would be similar to rates observed
in (46, XY) males, in effect, a rate lower than seen in (46, XX)
females. In reality, there are no published reports of classic (45,
XO) Turner’s syndrome with SLE, possibly due to a lack of speciﬁc
studies to address this question (Scoﬁeld et al., 2008). However,
Turner’s syndrome symptoms can occur in a range of karyotypes,
such as a mosaic (45, XO; 46, XX) female in which some cells are
XO and some are XX, or other situations in which only a por-
tion of the second X is present. SLE has been reported recently
in a Turner’s syndrome patient with a [46, XX del(Xq13-ter)]
karyotype in which there is one complete X chromosome but
much of the long arm of the second X chromosome is missing
(Cooney et al., 2009). There is a need for more analysis of the
relation between Turner’s syndrome and autoimmune diseases
to assess the frequency of co-occurrence and to decipher which
variations in the Turner’s syndrome scenario contribute to the
autoimmune disease symptoms. Toward this objective, a recent
study on a cohort of 798 Turner’s syndrome patients in Denmark
reported a rate of autoimmune disease comorbidity with Turner’s
syndrome at approximately double the rate for females of (46,
XX) karyotype, but the rate of predominantly female autoim-
mune diseases (e.g., Hashimoto’s thyroiditis) was 1.7x higher in
Turner’s syndrome females versus (46, XX) females (Jørgensen
et al., 2010). For other autoimmune diseases that typically have
a slight male predominance (e.g., Type 1 diabetes), the Turner’s
syndrome patients had a 5x higher rate than (46, XX) females.
The study did not report any cases of Turner’s syndrome with
SLE among the patients and only three cases of Turner’s syndrome
with RA.
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FIGURE 1 | Human sex chromosomes. (A) Normal female cells contain an
active X (Xa) and an inactive X (Xi). Since most X-linked genes are not
sex-speciﬁc, female cells really only need expression from one X, similar to
(B) the normal male. (C)Turner’s syndrome females typically have only one X
per cell but variations can occur. (D) Klinefelter’s syndrome males have an
extra X which is usually inactivated. For X inactivation to occur, it requires at
least two X inactivation centers (XICs) in close proximity so that a
stoichiometric-triggered random selection can be made as to which X to
inactivate, the maternally derived X or paternally derived X. Each daughter cell
will maintain inactivation of the same parentally derived X thereafter.
This general approach of analyzing the infrequent occurrences
of autoimmune symptoms in what might otherwise be considered
non-autoimmune disorders can be very beneﬁcial in expanding
our understanding of autoimmune diseases. But we must be open
to broad explanations that can involve genetics and/or epigenetics,
and can involve the innate immune response, the adaptive immune
response, and even events preceding any immune involvement.
AUTOIMMUNE DISEASES AND GENE SEQUENCES OF THE X
CHROMOSOME
In relation to the X chromosome, a few speciﬁc X-linked genes
have demonstrated an association with autoimmune diseases
(Figure 2). In some cases, the gene in question may have genetic
mutations, insertions, deletions, or duplications that alter the
gene product function and/or the levels of gene expression. In
other cases there might be epigenetic changes that alter the level of
gene expressionwithout changes in the underlyingDNA sequence.
The methyl CpG binding protein (MECP2), which suppresses
transcription by capping methylated DNA sites and recruiting his-
tone deacetylases, shows decreased MECP2 mRNA in association
with its contributing risk for lupus (Kaufman et al., 2012; Sawalha,
2013). This decreased MECP2 mRNA expression appears to result
from single nucleotide polymorphisms (SNPs) in the vicinity of
the MECP2 gene, SNPs that alter the gene expression but not the
functioning of the protein. The MECP2 gene is located at Xq28,
i.e., toward the end of the long arm of the X chromosome.
Another gene that has been linked to autoimmune diseases is
the interleukin-1 receptor-associated kinase 1 gene (IRAK1) which
is also located at Xq28 near theMECP2 gene. IRAK1 interacts with
the interleukin-1 receptor to up regulate a transcription factor,
nuclear factor κB activating protein (NKAP), which activates the
innate immune response. Several SNPs have been identiﬁed in the
DNA sequence in and around IRAK1. One mutation in the gene
leads to an S196F change in the IRAK1 protein which leads to
enhanced up regulation of NKAP and, thereby, contributes to an
increased risk for lupus (Kaufman et al., 2012).
Another gene linked to autoimmune diseases is CD40LG (a.k.a.
CD154), located at Xq24, which codes for a membrane protein
expressed at the surface of activated CD4 T cells (Banchereau et al.,
1994). CD40LG binds the costimulatory receptor CD40 on anti-
gen presenting cells, such as macrophages. This CD40–CD40LG
interaction then begins activation of an adaptive immune response
toward the antigen. In systemic sclerosis (SSc) CD40LG is overex-
pressed, which sets up an overly sensitive response (Lian et al.,
2012). The mechanism of this CD40LG overexpression is not yet
understood. However, epigenetic dysregulation is suspected since
demethylation of CD40LG on the inactive X chromosome of T
cells in lupus patients has been reported (Lu et al., 2007).
FOXP3 (forkhead box P3), also believed to have involvement in
some autoimmune diseases, is a key transcription factor control-
ling activation of regulatory T cells (Treg cells). The methylation
status of the gene FOXP3, which is located at Xp11.23, helps deter-
mine its expression which, in turn, induces other important genes
in the Treg cells, such as the T cell receptor (Kim and Leonard,
2007).
Human endogenous retrovirus are suspected of roles, possibly
reverse transcription activity, in autoimmune diseases (Le Dantec
et al., 2012; Nissen et al., 2013). Among these,HERV-Fc1, with only
one copy in the genome located at Xq21.33, has shown increased
expression in cases of MS (Nissen et al., 2012,2013; de laHera et al.,
2014). The means by which the increased expression of HERV-Fc1
occurs is not known but the occurrence of reverse transcription
may be detrimental for the cell since the reverse transcribed DNA
would be out of normal epigenetic context (e.g., not properly
methylated).
Another source of potential reverse transcription activity is the
long interspersed element, LINE1 (L1). L1 elements originated
from a functional gene that codes for reverse transcriptase activ-
ity (RNA to DNA) and endonuclease activity that aids in inserting
reverse transcribedDNA into the genome at new sites. L1 elements
comprise 17% of the human genome and there are estimated to
be more than 500,000 L1 element copies scattered throughout the
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FIGURE 2 | Human X chromosome features.The human X consists of a
short (Xp) and long (Xq) arm separated by a centromere. The XIC expresses
the X inactivation-speciﬁc transcript RNA (XIST RNA) which binds contiguous
chromatin and recruits enzymes involved in establishing epigenetic silencing.
LINE1 elements (L1) serve as anchoring sites for XIST RNA.Whereas L1
comprises 17% of the human genome, it comprises 34% of the X
chromosome (Ross et al., 2005). L1 content drops in Xp but consists of more
recently incorporated L1s, some still capable of reverse transcription. Lower
L1 content in Xp suggests potential difﬁculties in maintaining Xp inactivation.
Alu elements comprise ∼10.8% of the human genome but only 8% of the X.
However, the PAR1 region is 28.8% Alu. Alus contain an internal RNA pol III
transcription site but are usually suppressed by a positioned nucleosome.
human genome (Crow, 2010; Rodic and Burns, 2013). A deﬁnite
number is difﬁcult to obtain since most L1 element copies have
undergone mutations, particularly in the 5′ region, that alter their
sequence and disrupt their functionality in retrotransposition
activity. Often newer copies have inserted over old copies.
Althoughmost L1 elements have degenerated over time and lost
their function as reverse transcriptases, 80–100 copies are believed
to still be competent for retrotransposition activity (Alves et al.,
2000). Brouha et al. (2003) have mapped and analyzed most of the
L1s that are believed to be functional. They observed approx-
imately half of these viable L1 elements have varying degrees
of activity in cell cultures. In vivo, most L1 elements are sufﬁ-
ciently methylated to keep them inactive. However, recent reports
have demonstrated that, in lupus patients, some L1 elements are
hypomethylated in CD4+ and CD8+ T cells, B cells, and neu-
trophils (Nakkuntod et al., 2011; Brooks, 2014; Sukapan et al.,
2014). With hypomethylation, which usually coincides with his-
tone deacetylation, the L1 elements could become active. This
could include L1 elements with functional reverse transcriptase
activity (RNA to DNA conversion) and even functional retro-
transposition activity (RNA to DNA conversion and insertion into
the genome). But other L1 elements that become active, even if
they do not have functional reverse transcriptase activity, could
become problematic since they are frequently located in other
genes (intragenic location) and, in some sites, the L1 elements are
anti-sense to a larger gene. Expression of these L1 elements could
present alternate transcription sites disrupting normal expression
of the larger gene or anti-sense L1 element expression could create
ssRNA that hybridizes with the larger gene’s transcripts lead-
ing to dsRNA degradation and dampening of the larger gene’s
effects.
LINE1 elements are proposed to serve an additional function
with regards to the X chromosome besides their retrotransposition
activities, their potential as alternate transcription start sites, and
their potential as anti-sense interfering RNAs. There is an overall
twofold enrichment of L1 elements on the X chromosome (34%)
compared to the genome average (17%) but the enrichment is
in a gradient, higher in the X chromosome long arm (Xq) but it
becomes lower in the short arm (Xp; Ross et al., 2005). The L1 ele-
ments on the X chromosome are believed to function as anchoring
sites for the X-inactivation speciﬁc transcript RNA (XIST RNA)
that is expressed from the X inactivation center (XIC) at Xq13 and
spreads over contiguous chromatin in one of the two X chromo-
somes to silence genes and create the inactive X chromosome (Xi).
This is the basis of the Lyon repeat hypothesis (Lyon, 2006). Lyon
proposed that the XIST RNA anchors at the repetitive L1 elements
and recruits DNMTs and histone deacetylases to instill epigenetic
silencing of the underlying genes in the Xi. When X inactivation is
being established initially in early development of the embryo, L1
elements help with X inactivation by forming compartments that
sequester the inactive genes of the Xi into a dense core while tran-
scription occurs from young L1 elements at the surface of this core
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in an attempt to extend the silencing further into areas of genes
that can sometimes escape inactivation (Chow et al., 2010). The
ﬁnal result is silencing of approximately 75–85% of the genes on
the Xi but the intensity of silencing along the X decreases in par-
allel with the density of L1 elements, which is lower in the X short
arm (Xp) compared to the X long arm (Xq; Carrel and Willard,
2005; Lyon, 2006). The resulting Xi, (a.k.a. the Barr body) has a
dense perinuclear appearance with a core of inactive genes and
genes that escape inactivation at the surface. Once established,
the X inactivation state is maintained throughout the cell cycle
and is inherited by daughter cells. However, cellular stresses can
interfere with maintenance of the DNA methylation on the Xi
potentially allowing reactivation and expression of X-linked genes
from the Xi. The Xi with its perinuclear location, dense packaging,
and heavy requirement formethyl donors (S-adenosylmethionine,
SAM) is the last chromatin replicated in S phase which adds to the
difﬁculties in maintaining the properly silenced epigenetic state.
The X and Y chromosomes are believed to have originated
from a common autosome. Since then, the Y has decreased to
approximately 60 × 106 bps and contains approximately 100
genes including the SRY sex-determining gene. The X chro-
mosome has actually gained genes increasing to 153 × 106
bps and approximately 1,100 genes. Much of the newer mate-
rial is located in the Xp (Ross et al., 2005). L1 elements in
the Xp are considered to be younger copies (i.e., fewer muta-
tions) of which some are suspected of reverse transcriptase
functionality. Indeed, the work of Brouha et al. (2003), men-
tioned above, identiﬁed ‘hot L1’ elements, in effect, those
L1 elements containing complete functional sequences for the
L1 reverse transcriptase and which demonstrate some occa-
sional expression activity. Among these, the Ta-1d subclass is
one of the more active and frequently occurring L1 elements
with reverse transcriptase activity. At least two such sites of
‘hot L1’ elements were identiﬁed in the Xp by Brouha et al.
(2003) and this includes one site of particularly strong activ-
ity at Xp22 as determined from the Blast sequence AC004554
(http://www.ncbi.nlm.nih.gov/nuccore/AC004554.1; Myers et al.,
2002). Experimental activation of retroviral sequences by UVB
has been reported previously (Hohenadl et al., 1999) and, in
fact, expression of L1 elements was observed in RA (Neidhart
et al., 2000). Even earlier, retroviral activity had been pro-
posed for autoimmunity, including SLE (Herrmann et al., 1996;
Nakagawa and Harrison, 1996). Recently, more details have been
discerned that have begun the association of particular active
retroviral sequences with speciﬁc diseases (Hancks and Kazazian,
2012).
It is not simply that reverse transcription could occur, butwhich
RNA sequences are reverse transcribed, and when and where in
the cell the reverse transcription occurs that are important factors
with regards to involvement of reverse transcription in autoim-
mune diseases. Reverse transcribed DNA sequences that are rich
in CpG content will require extensive de novo methylation. This
may not be possible if the level of SAM, the cellular methyl donor,
is low or if the newDNA is not located near existingDNMTs. Since
most human DNMTs localize to the nucleus where they cooper-
ate in de novo and maintenance methylation of DNA and only
a minor amount of DNMT3a and DNMT3b is available in the
cytoplasm for de novo methylation (Kim et al., 2002), reverse tran-
scribedDNAcreated in the cytoplasmwouldbe less likely to receive
proper methylation. In lupus, the DNA targeted as autoantigenic
is CpG rich and has abnormal methylation patterns, primarily
hypomethylation of sequences (Krieg, 1995). In fact, the free DNA
in sera of lupus patients is enriched in Alu sequences, which have a
very high CpG content. Whereas Alu elements comprise approxi-
mately 10% of the human genome, the Alu content of free DNA in
sera of lupus patients has been observed to be as high as 55% (Li
and Steinman, 1989). One plausible explanation for this relative
increase in Alu DNA is reverse transcription of Alu RNA.
Alu elements on the X chromosome present very fascinat-
ing potential with regards to autoimmune disease mechanisms.
Alu elements comprise only 8% of the X chromosome, i.e., less
than the genome average (Ross et al., 2005). However, Alu ele-
ments constitute 29% of the pseudo-autosomal region 1 (PAR1)
at the end of Xp and 19% of the adjoining S5 region (Ross et al.,
2005). Alu elements average 300 bps and contain an intragenic
RNA pol III promoter, thus RNA pol III can create a com-
plete Alu RNA transcript from within the Alu element DNA (i.e.,
no 5′ promoter needed). With reverse transcriptase activity and
RNA pol III activity, there could be a rapid, even exponential,
increase in both Alu DNA and Alu RNA serving as templates for
each other. Normally Alu elements are kept silent with a nucle-
osome positioned over the RNA pol III promoter. Also, proteins
have been identiﬁed that bind Alu DNA elements and selectively
suppress RNA pol III transcription (Kropotov et al., 1999). How-
ever, the binding of some of these proteins is sensitive to the
methylation status of the Alu DNA (Cox et al., 1998). Among
the proteins that bind Alu DNA are the Ku proteins, often
seen as autoantigens in SLE (Tsuchiya et al., 1998). Methyla-
tion of the CpG rich Alu elements would also contribute to
their epigenetic packaging and suppression with subsequent his-
tone deacetylation and MECP2 capping. However, in S phase
as the DNA and Alu elements are replicated, there is a heavy
demand on SAM for methylation and on the supply of pro-
teins that reinforce Alu silencing. Silencing of Alu elements in
the heterochromatic inactive X chromosome would be partic-
ularly problematic since the Xi replicates later than the other
chromosomes and its extensive silencing requires availability of
suppressing proteins and an ample supply of SAM which may be
low by the time the cell enters late S phase. One potential problem
that could result following inadequate Alu silencing is interfer-
ence with assembly of signal recognition particles (SRP) which
have Alu domains (Brooks, 2012). Alu RNA transcripts could
compete with the SRP Alu domain for SRP9/14 heterodimers
resulting in incomplete SRP that cannot halt ribosome trans-
lation in the cytoplasm of extracellular proteins which would
normally be translated into the endoplasmic reticulum lumen
but now are exposed to cytoplasmic enzymes. Another poten-
tial problem is reverse transcription of Alu RNA by functional
L1 reverse transcriptases, such as from the ‘hot’ L1 sites in the
Xp (Brooks, 2014). Dewannieux et al. (2003) demonstrated that
L1 reverse transcriptases will preferentially reverse transcribe L1
RNA (1000x) and Alu RNA (300x) compared to other RNA tran-
scripts (1x). The Alu RNA transcripts and reverse transcribed
Alu DNA could disrupt and overwhelm the cell’s functions of
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methylation, translation, and translocation. There is an observed
phenomenon of Alu stress response in which many Alu elements
throughout the genome can suddenly be expressed due to shifting
of nucleosomes during stress (Kim et al., 2001). This shifting of
nucleosomes exposes intragenic RNA pol III transcription sites in
the Alu elements.
Another set of genes on the X chromosome that have bear-
ing on autoimmune diseases are the spermine synthase (SMS)
gene and the spermidine/spermine-N1-acetyltransferase (SAT1)
gene at Xp22.1. The enzymes from these genes are involved in
the polyamine pathway: SMS in biosynthesis of spermine from
spermidine and SAT1 in recycling of spermine to spermidine and
spermidine to putrescine. These two genes can, in effect, work
against each other leading to wasteful cycling through polyamine
synthesis and recycling. Since polyamine synthesis uses SAM,
this could adversely impact the availability of SAM needed for
DNA methylation. Normally SMS and SAT1 are silenced on the
Xi (Carrel et al., 1999; Carrel and Willard, 2005) but repeated
stresses could lead to cells in which these genes escape inacti-
vation, particularly since they are near other genes that normally
escape inactivation. SAT1 is particularly interesting in that it can
undergo superinduction (rapid increase in expression of 100x
or more) in response to cellular stress and SAT1 can acetylate
spermidine which can then be oxidized to putrescine (Chopra
and Wallace, 1998). Recently it was reported that SAT1 and
S-adenosylmethionine decarboxylase (AMD1) are elevated in RA
synovial ﬁbroblasts, along with putrescine which stabilizes AMD1
and is a precursor for polyamine synthesis (Karouzakis et al.,2012).
The polyamine pathway competes with cellular methylation for
the methyl donor SAM. Overexpression of SAT1 and SMS could
rapidly deplete SAM by futile polyamine synthesis and recycling.
The Toll-like receptor 7 (TLR7), located at Xp22.2, has recently
been determined to be associated with increased risk for lupus in
males in Chinese and Japanese populations when a SNP is found
in the 5′ untranslated region (UTR) of the gene (Shen et al., 2010).
Higher expression of TLR7 in B cells can cause an increase in type
1 interferon activity.
There are over 2,000 processed miRNAs identiﬁed so far origi-
nating from the human genome (Yan et al., 2014). Approximately
10% originate from the X chromosome. Some miRNAs are
involved in normal immune functions, such as TLR signaling,
IgG class-switching, and B cell differentiation (Pauley et al., 2009).
In addition, abnormal expression, processing, and/or functioning
of miRNAs have been determined in autoimmune diseases, such
as lupus (Tang et al., 2009; Zhao et al., 2011) and RA (Karouzakis
et al., 2009). Abnormalities related to X-linked miRNAs have been
proposed previously as causative in autoimmune disorders and
the female predominance of autoimmune patients (Pinheiro et al.,
2011).
One last category of DNA sequences in the X chromosome that
should be mentioned is fragile sites. Fragile sites are classiﬁed as
common (found in all or most members of a population) and rare
(found in 5% or less of population). So far in the human genome
30 rare fragile sites and 89 common fragile sites have been identi-
ﬁed (Debacker and Kooy, 2007). Fragile sites are stretches of DNA
that are particularly susceptible to altered rates of DNA replica-
tion, constrictions, breaks, gaps, and viral insertions in part due to
stalling and difﬁculties in sustaining smooth and complete repli-
cation through the stretches. This can lead to loss of genes, gaps
in the chromosome, difﬁculty in maintaining epigenetic control
or even fragmentation. Fragments that persist could then escape
normal epigenetic control and perhaps lead to abnormal distribu-
tion of genes among daughter cells. Alternate DNA conformations
(i.e., non-B-DNA) can occur in fragile sites and slow replication
until they are resolved. We can consider the inactive X chromo-
some to be particularly problematic with regards to replication
since it replicates late in S phase (in fact the last chromosome), it
has a limited time to effect DNA repair, and it requires extensive
DNA and histone methylation to attain proper repackaging. In
addition, the inactive X requires more scaffold attachment factor
A (SAF-A) to hold its dense perinuclear structure but SAF-A itself
requires methylation in order to translocate to the nucleus (Helbig
and Fackelmayer, 2003).
With regards to the X chromosome, three rare fragile sites with
their locations have been identiﬁed: FRAXA (Xq27.3, associated
with gene FMR1); FRAXE (Xq28, associated with FMR2); and
FRAXF (Xq28, associated with gene FAM11A) and three com-
mon fragile sites have been identiﬁed: FRAXB (Xp22.31); FRAXC
(Xq22.1); and FRAXD (Xq27.2; Debacker and Kooy, 2007). Asso-
ciations with speciﬁc genes for the X-linked common fragile sites
have not yet been made. These fragile sites typically replicate later
than neighboring non-fragile alleles. For example, fragile FRAXA
alleles at Xq28 replicate in the G2/M phase whereas neighbor-
ing non-fragile alleles replicate in late S phase (Hansen et al.,
1993). This late replication may be attributable to formation of
alternate non-B DNA structures (e.g., hairpins) within the fragile
site that hamper polymerase movement and function (Usdin and
Grabczyk, 2000). On the other hand, other sites, such as FRAXB,
show greater ﬂexibility in their fragile site DNA due to higher AT-
rich repeats interspersed with interruptions (Arlt et al., 2002). It is
conceivable that these fragile sites have difﬁculties during replica-
tion resolvingﬂuxing supercoiling stress that is released. InAT-rich
repeats the DNA strands may separate more readily (lower melt-
ing point) but then may form intra-strand hybridization that may
hamper smooth polymerase movement. The abundant Alu ele-
ments have the capability of such cruciform formation as seen in
the Alu domain of the 7SL RNA of the SRP. We should note that,
fragile sites are not necessarily the same as chromosomal break
points, but they often coincide or are in close proximity, such as
seen at the FMR1 gene in FRAXA (Verkerk et al., 1991).
X CHROMOSOME ABNORMALITIES AND AUTOIMMUNE
DISEASE SYMPTOMS
X-linked chromosomal abnormalities have been implicated in
many disorders, such as Fragile X, Turner’s, and Klinefelter’s syn-
dromes. As an example of possible associations of X abnormalities
and autoimmune diseases, chromosomal aberrations have been
reported in MS and many of those aberrations are related to
the X chromosome (D’Alessandro et al., 1990). A report on the
parent–child correlation in MS sheds further light on the MS and
X chromosome association (Sadovnick et al., 1991). This study on
a cohort of 75 parents with MS, showed that, among fathers with
MS, 21 of 22 had a daughter withMS and only one father had a son
with MS.Whereas, among the mothers with MS, 40 had daughters
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with MS and 13 had sons with MS. This strongly suggests that MS,
which has autoimmune aspects, is linked to the X chromosome
since the fathers contribute an X chromosome to their daughters
but not to their sons. Among sufferers of MS, men more often
transmit the disease to their children than women, a phenomenon
known as the Carter effect (Kantarci et al., 2006). A role for the X
chromosome in this transmission is highly suspected.
We can conclude from the preceding discussion of speciﬁc
X-linked genes associated with autoimmune diseases that loca-
tions all along the X chromosome can potentially be involved in
autoimmune diseases (Figure 2). However, the most signiﬁcant
vulnerabilities appear to be from Xp21 through PAR1, in effect,
the distal portion of the short arm of the X chromosome. Within
this section are: the FRAXB fragile site that can delay replication or
sustain breaks; polyamine genes that can impact SAM levels; ‘hot’
L1 genes that have functional reverse transcriptase activity; and
an abundance of CpG rich Alu elements. The high content of Alu
elements in this region requires extensive amounts of methylation
and protein suppressors to avoid their inappropriate expression
by RNA pol III and potential reverse transcription by L1 or other
reverse transcriptases. In the case of the inactive X chromosome,
there would be extensive packaging of the DNA to silence genes
and this packaging would contain ample supercoiling stress that
can add to the dynamics in chromatin disruption (Brooks, 2014).
This suspicion of Xp21 through PAR1 is reinforced by rare case
reports of non-autoimmune disorders that exhibit autoimmune
disease-like symptoms.
One such case,mentioned above, is a Turner’s syndromepatient
with a [46, XX del(Xq13-ter)] karyotype who has SLE (Figure 3A;
Cooney et al., 2009). Establishment of X chromosome inactivation
requires an XIC, located at Xq13, in each X chromosome so that
early in development, the XICs can be paired and a stoichiometric
buildup of interfering RNA transcript expression from the sense
and anti-sense strands in the XICs triggers a random choice as
to which X, the paternally derived or maternally derived, will be
inactivated (Augui et al., 2011). Each daughter cell will then keep
that same parentally derived X inactive. However, in this particular
patient, only one XIC exists since one X has a deletion of the Xq
arm from Xq13 to the terminus. Therefore, proper X inactivation
cannot be established. As a result, overexpression of X-linked genes
can occur, such as the polyamine genes at Xp22. For example, the
SAT1 gene can undergo superinduction when there is stress from
reactive oxygen species (ROS). In this patient’s situation there are
two available SAT1 alleles whereas normally with X inactivation,
one would be silenced (Brooks, 2013).
Another case is a male with severe lupus in which the male
is actually a [46, XX insert (Ypar1+sry)] karyotype (Figure 3B;
Chagnon et al., 2006). One X chromosome has insertion in its
PAR1 region of the sex determining SRY gene from theY chromo-
some and a portion of theY chromosome’s PAR1 region. This gives
a male phenotype but there is triplication of some PAR1 genes. X
inactivation would still be attempted. In those cells that choose
to inactivate the abnormal X, extension of X inactivation into the
abnormal region would be difﬁcult due to the low amount of
LINE-1 elements for anchoring the XIST RNA. This region could
remain active or be easily reactivated. As a result, this patient can
have overexpression of X-linked genes in this region.
Another situation arises in X-linked chronic granulomatous
disease (X-CGD), a rare immunodeﬁciency disease (Figure 4).
NADPH oxidase is needed in phagocytes to generate oxygen
radicals to destroy phagocytized pathogens. The activatedNADPH
oxidase consists of several subunits including a cytochromeb com-
ponent which includes a gp91-phox subunit coded by the CYBB
gene at Xp21.1 (Roos et al., 1996). The gp91-phox subunit facili-
tates the interaction of the cytochromeb componentwithNADPH
oxidase. However, in X-CGD, a variety of mutations, insertions, or
deletions in the CYBB gene disrupt gp91-phox with the end result
that the phagocytes cannot clear infections. Mothers are carriers
of this recessive disease since they have a second X chromosome
with a functionalCYBB gene. On the other hand, sons are sufferers
of X-CGD since they have only the abnormal CYBB gene and they
usually succumb at an early age to persistent infections that they
cannot clear. Although X-CGD normally does not entail autoim-
mune symptoms, there have been reports in which the CYBB gene
has insertion of genetic material such that there is duplication of
the X chromosome from Xp21.1 to the terminus. Brandrup et al.
FIGURE 3 | Lupus in patients with X chromosome abnormalities. (A) A
Turner’s syndrome patient with two X chromosomes but one X is missing
distal portions of Xq and does not have a complete XIC at Xq13 (Cooney et al.,
2009). As a result, X inactivation cannot occur and there is potential for
overexpression from Xp genes. (B) An XX male with insertion of portions of
the PAR1 and the SRY sex-determining gene from theY chromosome
presented severe lupus (Chagnon et al., 2006). Additional chromatin in Xp
may be difﬁcult to suppress epigenetically.
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FIGURE 4 | X-linked chronic granulomatous disease (X-CGD).
(A) X-CGD females are carriers of this recessive disease which is attributed
to a variety of abnormalities in the CYBB gene at Xp21.2. However, in
approximately half the cells, normal CYBB would be expressed from the
Xa. (B) X-CGD males do not have a normal CYBB gene and usually
succumb to persistent infections at an early age since they cannot clear
pathogens properly.
FIGURE 5 | X-CGD and lupus. (A) An X-CGD female with duplication of
chromatin from Xp21.2 to the distal end of the Xp suffered from lupus-like
symptoms (Brandrup et al., 1981). The additional Xp gene copies would
present difﬁculties in maintaining proper X inactivation. (B)There are only
three reports of lupus-like symptoms in X-CGD males since they succumb
at an early age whereas lupus typically appears later in early adulthood.
Only one of these cases had data regarding chromosome abnormalities
(Ortiz-Romero et al., 1997). In this case, the patient exhibited cutaneous
lupus. The X chromosome was a crossover at Xp21.2 between the mother’s
normal and abnormal X chromosomes.Whether this X abnormality
contributed to the lupus-like symptoms, and how it might contribute, are
not clear.
(1981) reported various lupus-like symptoms in female carriers of
X-CGD with the duplication of material from Xp21.1 through the
PAR1 (Figure 5A). Ortiz-Romero et al. (1997) reported a case of
X-CGDwith lupus-like lesions in amale suffererwhohad a recom-
binant X chromosome resulting from crossover of the mother’s
normal and abnormal X chromosomes (Figure 5B). These reports
suggest difﬁculties in the females in establishing and maintaining
X-linked dosage compensation. Other reports are available pre-
senting X-CGD with lupus and lupus-like symptoms (Schaller,
1972; Smitt et al., 1990; Manzi et al., 1991; Foti et al., 2004).
These cases of X chromosome abnormalities and autoimmune
diseases, along with the female predominance of autoimmune
diseases and the increased occurrence of lupus in Klinefelter’s syn-
drome (47, XXY) males compared to (46, XY) males, strongly
suggest that the X chromosome is involved. Furthermore, cases
of missing XICs and/or duplication of genetic material of the
Xp, particularly from Xp21 to the terminus, suggest the X short
arm, Xp, has a key role in autoimmune diseases. Unraveling the
contributions of the X chromosome in autoimmune diseases is
complicated by the natural phenomenon of X inactivation to
achieve dosage compensation of X-linked genes. Studying X inac-
tivation and loss of dosage compensation (a.k.a. reactivation or
escape from X inactivation) has proven difﬁcult. Much of our
studies on autoimmunediseases have usedmice as subjects. Genet-
ically, the mouse has been a good model since the human X
(153 × 106 bps) and the mouse X (161 × 106 bps) have 95%
of their genes in common (Boyd et al., 2000). However, studies on
the epigenetic control of the X chromosome are somewhat prob-
lematic due to differing X chromosome structures in the mouse
compared to the human (Figure 6). The human X chromosome
is submetacentric, meaning that there is a centromere between
the short arm (Xp) and the long arm (Xq). The mouse X chro-
mosome is telocentric, meaning that there is just one long arm
with a centromere at one end (Brown and Greally, 2003). The
X inactivation process initiating from the mouse XIC can spread
easily throughout the length of the mouse X. In the human X,
the X inactivation process must cross the centromere before it
can cover the Xp arm and, as mentioned previously, the amount
of L1 elements drops in the Xp, providing fewer anchoring sites
for the XIST RNA (Ross et al., 2005; Lyon, 2006). Therefore, we
would expect genes on the human Xp, including genes such as
SAT1 and SMS, to be more vulnerable to reactivation following
cellular stresses when compared to genes on the human Xq or
on the mouse X. However, this vulnerability is difﬁcult to study
since the extent of X inactivation can vary from cell to cell among
somatic cells. In addition, when studying the potential for step-
wise reactivation of X-linked genes on the human Xi, such as Xp
genes, the mouse Xi does not work well as a model since it shows
an ‘all or nothing’ response to demethylating agents, either there
is no partial reactivation or, with a little more agent, everything
on the mouse Xi reactivates. The mouse Xi lacks the distinct dif-
ferences that exist between the human Xp versus Xq. Another
difference between the human and mouse X chromosomes is the
content of Alu elements. We have mentioned that Alu elements
comprise more than 10% of the human genome and the PAR1
region of the X chromosome is 29% Alu. This high concentration
of Alu elements could be problematic if there was sudden expo-
sure to RNA pol III during an Alu stress response as described by
Kim et al. (2001). The results could potentially include: disruption
of SRP assembly and disruption of extracellular protein synthe-
sis; reverse transcription of Alu elements by L1 or HERV reverse
transcriptases; and opening of neighboring genes that were pre-
viously sequestered for dosage compensation. On the other hand,
the mouse genome does not include any signiﬁcant amounts of
Alu elements but it does have an abundance of B1 elements, which
are also short interspersed elements (SINEs) also derived from the
7SL RNA of the SRP, accounting for 7% of the mouse genome
(Tsirigos and Rigoutsos, 2009). The mouse genome also contains
0.7% B2 elements which are SINEs derived from tRNA (Ferrigno
et al., 2001). Stress can induce increased expression of mouse B1
and B2 SINEs similar to the human Alu stress response (Li et al.,
1999). However, it is the high concentration of Alu elements in
the human Xp and the location of the inactive X chromosome
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FIGURE 6 | Comparison of human and mouse X chromosomes.The
human X (153 mb) and the mouse X (161 mb) are ∼95% similar in gene
content but are signiﬁcantly different in the arrangement of genes and
overall structure (Boyd et al., 2000). The human X is submetacentric with a
centromere separating its arms. The mouse X is telocentric with only one
arm and a centromere-like structure at one end. X inactivation can spread
unencumbered on the mouse X since there is no centromere or L1
gradient to negotiate. For example, the SAT1 and SMS genes are on the
other side of the centromere from the XIC in the human X but no such
barrier exists in the mouse X. Inset: Human ﬁbroblast stained with
ﬂuorescein-tagged anti-histone H1.2 antibodies highlights the inactive X
chromosome (Xi), showing its dense heterochromatic character, perinuclear
location and its proximity to nucleoli. This places one of the most inactive
structures, Xi, close to one of the most dynamic and multi-functional
structures, the nucleolus.
that could contribute to signiﬁcant initiating events in human
autoimmune diseases.
PROXIMITY OF THE INACTIVE X CHROMOSOME TO THE
NUCLEOLUS
The inactive X chromosome (Xi) is typically observed as a dense
heterochromatic structure in a perinuclear location, as if it has
been pushed aside by the more active chromatin. This can help
explain the late replication of the Xi relative to other chromosomes
since it is less accessible but requires more effort in unpacking,
repairing, and replicating DNA, and then repacking into hete-
rochromatin. It places greater demands on methylation for DNA,
histones, and translocation of other chromatin proteins, such as
SAF-A. This is further complicated by the fragile sites with alter-
nate DNA conformations that must be resolved but the transient
release of stored negative supercoiling stress from nucleosomes
during replication can add to the formation of alternate DNA
conformations, such as Z-DNA (Brooks, 2013).
Studies have shown that the Xi associates with nucleoli dur-
ing S and G2 phases and an estimated one-third of inactive X
chromosomes remain in close proximity to the nucleoli during
most of the cell cycle (Bourgeois et al., 1985; Zhang et al., 2007).
Zhang et al. (2007) proposed that this Xi-nucleolus association
may be required to maintain the X inactivation status of the
Xi. This spatial association of the Xi and nucleolus then puts
the many vulnerabilities of the inactive X chromosome within
close proximity of one of the most dynamic and multi-functional
components of the cell, the nucleolus (Figure 6, Inset). We can
begin to imagine the consequences of this Xi-nucleolus association
that might occur if a nucleolus increases its synthetic activi-
ties to produce ribosomes, tRNAs, SRPs, splicing components,
and other macromolecular structures. The nucleolus increases
in size, pushing aside most DNA in order to provide space for
the folding of nascent RNA transcripts followed by their asso-
ciation with nascent proteins into ribonucleoprotein complexes.
As the nucleolus increases in size, it could engulf part or all of
the Xi. Since the nucleolar synthesis uses RNA polymerases I and
III (RNA pol I and III) to produce many of the specialized non-
coding RNA transcripts, the Xi could then be exposed to RNA
pol III that could transcribe many of the Alu elements, including
in PAR1. RNA pol III transcribes genes for non-coding RNAs
such as the 7SL RNA of the SRP, the U6 RNA, the 5S rRNA
of the ribosome, tRNAs, and SINEs (MIR and Alu; Noma and
Kamakaka, 2010). The nucleolus contains abundant RNA pol
III including a perinucleolar compartment that contains a very
high concentration of RNA pol III protein and nascent transcripts
(Matera et al., 1995). Many of these transcripts are associated
with the Ro and La proteins that are frequently autoantigens in
SLE and are believed to serve as chaperones in the early pro-
cessing of RNA pol III transcripts (Rinke and Steitz, 1985). We
should also note that RNA pol III requires fewer transcription
factors than RNA pol II and does not require ATP to support its
progression.
Now consider the Xi-nucleolus interactions when there is cel-
lular stress that results in an Alu stress response and/or a nucleolar
stress response. We should focus, in particular, on the cluster of
Alu elements in the X PAR1 region of the Xp and its close prox-
imity to RNA pol III in the nucleolus. Other Xi vulnerabilities in
this region are also important to consider: the ‘hot’ L1 elements,
the fragile sites that can delay replication and the polyamine genes,
SAT1 and SMS, which compete for SAM, the methyl donor.
The Alu stress response can lead to selective opening and
expression of Alu transcripts (Liu et al., 1995; Kim et al., 2001).
The Alu stress response involves shifting of nucleosomes to expose
the intragenic RNA pol III promoter sites and displacement of
any Alu binding proteins. Two proteins that have been proposed
as Alu binding proteins are the Alu co-repressor 1 (ACR1) pro-
tein (Kropotov et al., 1999) and the Ku antigen which binds a
GGAGGC motif in the Alu core sequence, possibly in associa-
tion with the TATA-binding protein (TBP; Tsuchiya et al., 1998).
Opening of the Alu elements would release stored negative super-
coiling stress from the disrupted nucleosomes and that stress will
ﬂux through the region transiently disrupting other nucleoprotein
complexes, such as those involved in the XIST RNA anchoring or
the supercoiling stress could transiently ﬂip stretches of DNA into
alternate conformations, such asZ-DNA,which could be stabilized
by increased polyamines and nuclear aggregates of polyamines
(NAPs; Brooks, 2013).
Nucleolar stress responses can take many forms and involve
changes in the nucleolar morphology (Hernandez-Verdun et al.,
2010). Often it entails redistribution of nucleolar proteins, changes
in the active synthetic pathways being processed and even changes
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in the size of the nucleolus. Boulon et al. (2010) refer to the “spa-
tial proteomics” of the nucleolar proteins since the changes can
include redistribution between the nucleoli, nucleus, and cyto-
plasm. As for the size changes, depending on the type of stress,
the nucleolus may appear to shrink and even dissolve but viral
infections tend to cause an increase in nucleolar size as the active
virus induces the nucleolus to increase production of ribosomes
and tRNA for viral protein synthesis and increase expression
and processing of viral RNA transcripts (Hiscox, 2007; Greco,
2009).
These stress induced changes in the nucleolus could potentially
impact the nearby Xi, even engulﬁng the Xi and exposing it to
nucleolar contents. In this scenario the abundant Alu elements in
Xp PAR1 could be exposed to the high levels of RNA pol III in the
nucleolus. This could lead to a sudden increase inAlu transcripts in
the nucleolus that could interfere with the SRP assembly and func-
tion, as described previously (Brooks, 2012). Brieﬂy, competition
betweenAlu domains in the 7SL RNA of the SRP and the Alu RNA
transcripts from Xp PAR1 and elsewhere would lead to incomplete
SRPs that cannot halt translation by the ribosome when the signal
recognition domain reads the signal for an extracellular protein.
In such a scenario, the extracellular protein would be expressed
in the cytoplasm rather than the endoplasmic reticulum and the
nascent protein would be inappropriately exposed to cytoplas-
mic enzymes, such as peptidylarginine deiminases (PADs) and
transglutaminases. The abundance of Alu RNA transcripts could
be reverse transcribed by ‘hot’ L1 reverse transcriptases, such as
the ones at Xp22, which could create an abundance of hypomethy-
lated Alu DNA (Brooks, 2002). This could explain the abundance
of Alu DNA (55% of the free DNA) in SLE sera as reported by Li
and Steinman (1989).
POLYAMINE INTERACTIONS IN THE NUCLEOLUS
The polyamines are highly charged polycations that serve many
essential functions in the cell (Figure 7; Moinard et al., 2005; Pegg,
2009; Igarashi and Kashiwagi, 2010). For example, polyamines
can control splicing and translation of their own enzymes for syn-
thesis (ornithine decarboxylase, ODC; Persson et al., 1988) and
recycling (spermidine/spermine N1-acetyltransferase; Hyvönen
et al., 2006). Polyamines are important for modulating changes
in chromatin structure (Visvanathan et al., 2013) and they are
important for regulating RNA synthesis in the nucleolus (Whelly,
FIGURE 7 | Polyamine synthesis and recycling. Polyamine synthesis is
tightly controlled since it competes for SAM with cellular methylation
(DNA and histone methylation, protein and RNA localization facilitated by
methylation). ODC and AMD1 are key enzymes since ODC produces
putrescine, the polyamine precursor, and putrescine can allosterically
increase AMD1 activity. However, induction of SAT1 can recycle
polyamines to putrescine, which then activates AMD1 and polyamine
synthesis. Key: ODC, ornithine decarboxylase; SAM,
S-adenosylmethionine; PAO, polyamine oxidase; AMD1, SAM
decarboxylase; SAT1, spermidine/spermine-N1-acetyltransferase; dcSAM,
decarboxylated SAM; SDS, spermidine synthase; MTA, methyl
thioadenosine; SMS, spermine synthase.
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1991). For this discussion, we will focus primarily on the abil-
ity of polyamines to stabilize alternate conformations of nucleic
acids and on the ability of polyamines to aid in RNA folding,
protein folding and nucleoprotein complex assembly that occurs
in the nucleolus. In fact, the majority of spermidine and sper-
mine are believed to be associated with RNA and, to a lesser
extent with DNA. In addition, the nucleolus, site of RNA folding
and ribonucleoprotein assembly (SRP, ribosomes, tRNAs, splicing
components, and more), has a high concentration of polyamines
that can change rapidly as needed in response to cell cycling and
cellular stresses (Gfeller et al., 1972; Shin et al., 2008). We should
still bear in mind, however, the impact of increased polyamine
synthesis which lowers the levels of SAM available for cellular
methylation important in epigenetic silencing and protein and
RNA trafﬁcking.
RNA folding is more efﬁcient with higher charged counteri-
ons. Divalent ions like Mg+2 require millimolar concentrations
whereas trivalent ions like spermidine can work at micromolar
concentrations in in vitro experiments that follow steps in RNA
folding (Koculi et al., 2004; Woodson, 2004). The dense charge of
a Mg+2 ion can organize multiple water molecules into a shell of
one or more hydration layers around the Mg+2 making it a bulkier
hydrated counterionwhen it does interact withRNA (Draper et al.,
2005). And so the charge density and distribution over the length
of the counterion is a factor. The+3 charge of spermidine is spread
over ∼13 Å with the individual +1 charged amines separated by
alkyl linkers, thereby reducing the extent of organized hydration.
On the other hand, the +3 charge of a hexamminecobalt(III)
counterion is focused at the metal but has a 6 Å length due to the
amino groups. The hydration shell is more compressible such that,
in experiments with DNA, water molecules can be displaced and
at least two direct interactions of the hexamminecobalt counte-
rion with the nucleic acid can be formed (Kankia et al., 2011). As
such, with the combination of dense high charge and compressible
hydration, the hexamminecobalt is more efﬁcient at in vitro exper-
imental RNA folding than spermidine (12 μMcobalt hexamine vs.
55 μM spermidine) but the spermidine is the more relevant coun-
terion for the in vivo setting (Woodson, 2004). The polyamines,
spermidine and spermine, provide a very effective combination
of charge and length for the dynamic hydration and dehydration
of nucleic acids and counterions that are important in facilitating
RNA folding and the polyamines are effective at lower concen-
trations than competing counterions. The nucleolus is the site of
much of the cell’s RNA folding activity and, therefore, we see a
close relation between polyamine levels and nucleolar activity.
Polyamines are important for RNA folding but they are not
necessarily a component of the ﬁnal RNA or ribonucleoprotein
moiety. As shown in Figure 8, a spermine molecule is located
FIGURE 8 | Polyamine involvement in RNA folding and ribonucleoprotein
assembly. Spermine is involved at a key location in tRNA to stabilize the ﬁnal
RNA conformation as seen in the yeast phenylalanine tRNA structure
(1EVV.pdb from the Protein Data Bank: www.rcsb.org; Jovine et al., 2000).
Polyamines are involved in RNA folding and ribonucleoprotein assembly in
nucleoli as transient factors initiating folding and as stabilizing factors in the
ﬁnal macromolecular complexes. Xaplanteri et al. (2005) identiﬁed more than
30 sites in the 23S rRNA and more than 100 sites in the 50S ribosomal
subunit at which spermine or spermidine could potentially interact with the
RNA and proteins.
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in the ﬁnal structure at a central site in the yeast phenylalanine
tRNA where the spermine can stabilize the bent RNA structure
(Jovine et al., 2000). On the other hand, a yeast branchpoint-U2
snRNA structure does not show any spermine molecules in the
crystal structure but spermine at 1–3 mM is required during
the crystallization to obtain the structure including the unpaired
adenosine bases that protrude out as part of their function in
the nucleophile attack on 5′ splice sites (Berglund et al., 2001).
In this structure, the spermine may be randomly positioned and
not provide sufﬁcient diffraction data to determine the spermine’s
position(s) or the spermine is required only transiently in the fold-
ing process. Another interesting study investigated binding sites
for spermine or spermidine in the 23S rRNA and the 50S sub-
unit of the bacterial ribosome, which consists of the 23S rRNA, a
5S rRNA, and 33 proteins (Xaplanteri et al., 2005). Using a pho-
toactivated crosslinking agent, N1-azidobenzamidino spermine
(ABA-spermine), the authors identiﬁed more than 40 sites in the
23S rRNA and more than 135 sites in the 50S subunit where the
polyamines could potentially interact with the RNA. This sug-
gests that the polyamines could help with the initial folding of
the 2,094 bases of the 23S rRNA and be involved in the ﬁnal
ribonucleoprotein assembly.
Although the polyamines are important in RNA folding and
assembly of macromolecular complexes and the polyamine lev-
els increase during stress to facilitate increased production of
ribosomes, tRNAs, SRPs, and splicing components, there can
be consequences if the polyamine levels are not controlled. An
increase in putrescine can support the formation of NAPs which
can stabilize infrequent conformations inDNA,RNA,and proteins
(Brooks, 2013). At the same time, the larger NAPs would not be as
efﬁcient as individual spermine or spermidine molecules in RNA
folding. Another potential problem with excess polyamines in the
cell is that polyamine recycling can generate acrolein. Acrolein
is very reactive and can be toxic to cells. Appearance of acrolein
conjugated proteins closely parallels the severity of SjS episodes
(Higashi et al., 2009). In addition, polyamines can be conju-
gated to proteins by transglutaminases, potentially altering their
immunogenicity (Haddox and Russell, 1981; Agostinelli, 2014).
And we should not overlook the allosteric effect of putrescine
on AMD1 in reducing SAM levels, thereby impacting cellular
methylation required for DNA and histone epigenetic control
and for RNA and protein movement among cellular locations.
Finally, the polyamines can impact the rate of Xi replication
by stabilizing alternate DNA conformations, such as in fragile
sites. This can slow the late S phase replication and reforma-
tion of Xi heterochromatin signiﬁcantly so that portions of the
Xi may not complete their replication until after S phase, if they
complete at all. The Xi then becomes vulnerable to altered gene
expression, mutations, breaks, translocations and even loss of
the Xi. It has been reported in the context of breast cancer that
loss of the Xi can lead to duplication of the active X which
would result in overexpression of X-linked genes (Richardson
et al., 2002). Such duplication has been reported in autoimmune
diseases (Invernizzi et al., 2009). And we should suspect that,
on some occasions when there is difﬁculty with the Xi, such
as delayed replication, the subsequent segregation of chromo-
somes could be affected such that there is uneven distribution
between daughter cells resulting in a mosaic of XO, XX, and XXX
cells.
GENERATION OF AUTOANTIGENS
When a pathogen enters a cell and uses the cellular machin-
ery to replicate itself, the nucleolus is a prime target for the
pathogen because of the importance of the nucleolus in cellu-
lar synthesis and replication (Boisvert et al., 2007; Bierne, 2013).
The pathogen requires the cell’s ribosomes and tRNAs to syn-
thesize the pathogen’s proteins. And the pathogen can use the
cell’s polymerases to generate pathogen RNA transcripts which are
folded in the nucleolus. Many pathogenswill ﬁrst induce increased
polyamine synthesis to support the increased nucleolar activity
they require (Goyns, 1981). We use Epstein-Barr virus (EBV) as a
prime exemplary pathogen to convey the concepts leading to tissue
degeneration and autoimmune responses attributable to pathogen
infections. Other pathogens, such as hepatitis B virus (HBV; Maya
et al., 2008) and varicella zoster virus (VZV; Rodriguez-Violante
et al., 2009), are also proposed as having a role in some cases of
autoimmune diseases, and those pathogens may follow similar
patterns as EBV in the development of autoimmune diseases. In
fact, it may be that, once the host cells are compromised by one
pathogen, subsequent stress by other pathogens (bacterial or viral)
or agents (heavy metals, heat shock, or drugs) can follow simi-
lar paths and trigger additional bouts that take advantage of the
prior disruption. In the case of EBV, it induces increased c-MYC
activity (Bajaj et al., 2008) which induces increased expression of
ODC, SMS and SDS, thereby increasing polyamine synthesis and
consumption of SAM (Bello-Fernandez et al., 1993; Dang, 1999;
Nilsson et al., 2005). EBV also upregulates RNA pol III transcrip-
tion to generate RNA for ribosomes and tRNAs as well as for
expression of viral RNAs ( Gomez-Roman et al., 2003; Felton-
Edkins et al., 2006). This could entail active transcription from
newly exposed Alu elements.
As the nucleolus swells with the abnormal increases in
polyamines and RNA processing, the nucleolus can engulf the
Xi and expose it to the polyamines and RNA pol III (Figures 9
and 10). With the increased polyamines and RNA transcripts,
including Alu RNA, there can be misfolding of RNA and potential
stabilization of this abnormal RNA by polyamines and NAPs. For
example, Alu RNA can form cruciforms that could be stabilized by
polyamines and NAPs into autoantigens. These RNA transcripts
can incorporate the Ro protein into autoantigenic complexes since
the function of Ro is to identify misfolded RNA (Figure 11; Stein
et al., 2005). Ro is often an autoantigen in lupus. Excess polyamines
andNAPsmay hinder refolding or degradation of the RNA leaving
the complex as an autoantigen. Likewise, The La protein associates
withRNApol III genes to chaperone the transcripts throughnucle-
olar processing (Figure 11; Fairley et al., 2005). In an autoantigenic
complex of polyamines, RNA and Ro or La, the proteins (Ro and
La) would be constant epitopes and thereby take part in eliciting
an autoimmune response (anti-SSA/Ro, anti-SSB/La antibodies).
Epitope spreading, initiated from autoantigenic RNA, DNA or
proteins could eventually involve reactions to less conformation-
ally compromised material, i.e., the more natural endogenous
conformations could be targeted in later stages of an autoimmune
response.
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FIGURE 9 | Co-localization of inactive X chromosome with the nucleolus.
Depiction of a typical cell, such as a ﬁbroblast, with the nucleolus and Xi in
close proximity. This association suggests involvement of the nucleolar
machinery in maintenance of the inactive state of the Xi. The Xi is seen in this
close association 80–90% of S phase cells and approximately one-third of
cells throughout interphase (Zhang et al., 2007).
FIGURE 10 | Pathogen impact on nucleolar activity. When a
pathogen, such as Epstein-Barr virus (EBV), enters a cell, it will
attempt to use cellular machinery to replicate itself. This includes using
the nucleoli to process pathogen RNA transcripts and increase
ribosomes and tRNAs to produce the pathogen’s proteins. In the case
of EBV, it can use the human lymphocytic antigen (HLA) to enter the
cell (Li et al., 1997). It then induces increased RNA pol III and c-MYC
activity, which induces increased activity of polyamine synthesis
enzymes: ODC, SDS, and SMS. This reduces SAM while increasing
polyamines. Much of the polyamines localize to the nucleoli to aid in
RNA processing, thereby causing the nucleoli to swell in size as more
room is needed for the increased processing. The enlarged nucleoli
could potentially engulf the Xi and expose the Xi to the nucleolar
abundance of polyamines and RNA pol III.
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FIGURE 11 | Initiation of autoantigen formation. Polyamines and nuclear
aggregates of polyamines (NAPs; Brooks, 2013) could stabilize alternate DNA
conformations in the Xi which could slow replication and packaging of Xi
chromatin, especially in fragile sites. Disruption of the Xi could expose Alu
elements to RNA pol III, generating an abundance of Alu RNA. Excess Alu
RNA can disrupt SRP assembly leading to difﬁculties in translation of
extracellular proteins (Brooks, 2012). Alu RNA may be stabilized in
autoantigenic conformations by polyamines or NAPs. Association of Alu RNA
with Ro and La proteins, which aid in processing of RNA pol III transcripts,
could incorporate Ro and La into autoantigens. Expression of L1 from the Xi
could lead to L1 protein that reverse transcribes Alu RNA to DNA. This Alu
DNA would be hypomethylated and could bind Ku and nascent histones in the
cytosol. These would be autoantigenic since they are outside their normal
epigenetic context. These autoantigens could be released extracellularly
through apoptosis, NETosis or ETosis. This can include degradative enzymes,
such as peptidylarginine deiminase 4 (PAD4; Brooks, 2013).
The excess Alu RNA transcripts generated from the Xi can
disrupt the assembly of SRP since the Alu RNA can compete with
the Alu domain in the 7SL RNA of the SRP for SRP proteins SRP9
and SRP14 (Brooks, 2012). This can leave the SRP lacking the
ability to halt translation of extracellular proteins by the ribosome,
exposing those proteins to intracellular enzymes they would not
normally encounter. In addition, the excess Alu from the Xi could
become substrate for reverse transcription by L1 reverse tran-
scriptase protein that may be expressed from the Xi. The reverse
transcribed Alu DNA would be hypomethylated if it is created in
the cytosol away from the nuclear DNMTs. Also, these transcripts
could bind the Ku protein, another frequent autoantigen in lupus,
since Ku binds GGAGGC sites found in Alu DNA (Tsuchiya et al.,
1998; Tutrjs and Tuteja, 2000). This rapid generation of Alu DNA
could also yield more Alu RNA since the Alu elements have an
internal RNA pol III site. The abundance of Alu DNA that would
result from reverse transcription can help explain the observation
by Li and Steinman (1989) that free DNA in lupus patients’ sera
is 55% Alu and the observation of Alu retrotransposition induced
by stress (Hagan et al., 2003). Nucleolin, a major protein in the
nucleolus, is involved in decondensation of chromatin, processing
of RNA transcripts and maturation of ribosomes. Nucleolin can
be targeted as an autoantigen (Minota et al., 1991). This may also
be due to the abnormal activity occurring during nucleolar stress.
Other nucleolar material, such as tRNAs and splicing components,
could be stabilized in abnormal conformations or complexes with
polyamines and due to imbalance in RNA processing components,
such as Ro and La.
One ﬁnal concept that we should consider is that the increased
polyamines and NAPs in the nucleolus and nucleus could disrupt
miRNAand lncRNAconformations andprocessing such that there
is dysregulation of the expression levels of their targeted genes. The
broad multi-target aspects of miRNAs could result in quite expan-
sive disruption of protein expression in cells with very complicated
effects.
FUTURE DIRECTIONS
Muchof the research on autoimmune diseases in the past has taken
a genetic approach with the idea that we would ﬁnd the elusive
‘lupus’ gene or the ‘MS’ gene, much like the concept that muta-
tions in a speciﬁc gene often have an important role in cancers.
SNP studies and genome-wide association studies (GWAS) have
identiﬁed genes that have statistical signiﬁcance in speciﬁc autoim-
mune diseases but that still leaves a vague picture of the ‘cause and
effect’ in explaining triggering events and progression. Epigenetics
as a factor in autoimmune diseases has been gaining interest in the
past decade but many researchers still have a genetics-based per-
spective of epigenetics, that screening for the methylation state
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of genes will uncover the hypomethylated or hypermethylated
‘lupus’ gene. But epigenetics also involves sections of chromatin
between genes such that potential problems can initiate with-
out speciﬁc genes being involved. For example, release of DNA
supercoiling stress stored in nucleosomes can ﬂux through the
chromatin and disrupt sites 1000s of bps away, opening loops of
chromatin with genes and pseudogenes that were previously sup-
pressed but now have exposed promoter regions. If we think of
Alu elements with all their copies as being genes, albeit small non-
coding genes, then there is not one single ‘lupus’ gene but more
than a million. That still leaves us short of an explanation for the
triggering and progression of autoimmune diseases. We have to
think of the higher levels of epigenetics that can be involved, such
as X inactivation and its potential for disruption with subsequent
overexpression or loss of X-linked genes. And we have to think
of epigenetic control as stored potential, not just for individual
gene expression, but for DNA stress that can have far reaching
impact on gene packaging and DNA conformations. Epigenetic
changes can also involve subtle events, such as transient appear-
ance and possible stabilization of alternate DNA conformations
in a fragile site that then delay the completion of DNA repair or
replication, placing the entire chromosome in jeopardy of degra-
dation or misallocation during cell division so that daughter cells
inherit different amounts of chromatin. Among the many com-
ponents in epigenetic control (small non-coding RNAs, histones,
MECP2, counter ions, etc.) the polyamines are particularly inter-
esting due to their versatility, their unique combination of charge
and length, and their involvement in RNA folding, nucleoprotein
assembly and episodes of cellular stress. In addition, their ability
to form aggregates, NAPs, when sufﬁcient putrescine, spermidine,
and spermine are available can be potentially evenmore detrimen-
tal by stabilizing autoantigenic conformations of nucleoprotein
complexes. The importance of polyamines in nucleolar activities
places the polyamines in a critical position during cellular stress
when the most inactive component in the nucleus, the inactive X
chromosome with all its vulnerabilities, could be engulfed by the
most active and dynamic component of the nucleus, the nucleolus.
Looking at a list of autoantigen types in lupus, the mystery clears
somewhat aswe realize thatmost can be grouped as components of
chromatin (DNA, histones) or components of the nucleolus (Ro,
La, RNA, etc.). Still, we must keep in mind that there are other
possibilities. For example, the DNA may be reverse transcribed
DNA in the cytosol and the histones may be nascent histones in
the cytosol that bind the reverse transcribed DNA.
The differences between the human and mouse X chromo-
somes present difﬁculties in using mouse models of autoimmune
diseases. On one hand, the mouse adaptive immune response can
give us good insights on events in the human adaptive immune
response. On the other hand, X-linked events that precede the
adaptive immune response may not compare as well since the
human X appears more vulnerable to loss of dosage compensation
and has unique problematic components, such as Alu elements,
“hot” L1 elements, and X-linked polyamine genes that may reac-
tivate more readily. The mouse X chromosome does not present
these same vulnerabilities to the degree that we canmodel progres-
sive loss of dosage compensation suspected to occur in the human
Xi. On the other hand, the mouse models do show the possible
involvement of polyamines since spontaneous lupus symptoms
in the NZB/W lupus mouse model can be suppressed with the
addition of diﬂuoromethylornithine (DFMO) to the drinking
water (Thomas and Messner, 1991). DFMO is a known inhibitor
of ODC , the initial enzyme in polyamine synthesis. The Jimpy and
Quaking mouse models show an accumulation of polyamines that
accompanies an increasing myelin deﬁciency (Russell and Meier,
1975). This could be modeling the tissue damage that occurs in
human MS. And overexpression of SAT1 in mice leads to hair loss
(Suppola et al., 1999). This could be a model of our proposed
overexpression of human X-linked SAT1 in autoimmune diseases
when there is disruption of the inactive X chromosome with sub-
sequent loss of dosage compensation for SAT1. Hair loss occurs as
a symptom in lupus and MS.
We expect that, as the autoimmune disorder research commu-
nity gains more understanding of epigenetics and its potential,
there will be more projects that are based on hypotheses of epi-
genetics involvement and less emphasis on ﬁnding speciﬁc genes
and mutations. In addition, while mouse models are of value in
understanding the adaptive immune response, the mouse mod-
els must be reappraised for their value in studying the innate
immune response and early events that precede the autoimmune
reaction. Projects targeting the adaptive immune response are
of value in determining how to reduce the autoimmune reac-
tion however our hypotheses suggest that projects that increase
our understanding of the innate response, cellular and nucleolar
stress responses and the stability of the inactive X chromosome,
may well prove to be more beneﬁcial in preventing and curing
autoimmune disorders. Drug discovery targeting PAD enzymes to
reduce NETosis, targeting pathogens, such as EBV, targeting other
enzymes involved in epigenetic control and targeting polyamine
synthesis and recycling enzymes should prove of greater value for
eventual clinical use for prevention and control of autoimmune
disorders.
SUMMARY
We have described the vulnerabilities of the inactive X chromo-
some which include its need for extensive heterochromatic assem-
bly and maintenance, its perinuclear localization, its proximity to
the nucleolus, and the potential detrimental actions that can arise
from Alu elements, L1 elements, fragile sites, polyamine genes,
miRNAs, and HERVs. The nucleolar stress response, such as the
impact of pathogen activity exempliﬁed by EBV,can lead to engulf-
ment of the Xi by the nucleolus and exposure of the Xi to the high
concentrations of polyamines and RNA pol III. Abnormal expres-
sion of previously sequestered alleles on the Xi, such as miRNAs
and Alu and L1 elements, can alter the nucleolar activity and gen-
erate polyamine-stabilized (and possiblyNAP-stabilized) alternate
(misfolded) conformations of RNA and DNA, proteins and nucle-
oprotein complexes that are potentially autoantigenic. Constant
epitopes, such as Ro, La, or Ku proteins, within these abnormal
nucleoprotein complexes could also become autoantigenic targets.
These autoantigens can then be exposed extracellularly where they
elicit an autoimmune reaction. The extracellular exposure of these
autoantigens can occur through apoptosis, NETosis (neutrophil
extracellular trap release), ETosis, or cell surface presentation. This
hypothesis: ‘X chromosome-nucleolus nexus’ ﬁts well with the
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previously published ‘NAPs in NETs’ hypothesis (Brooks, 2013).
Together these hypotheses provide explanations for many of the
autoantigens encountered in autoimmune diseases and they point
to loss of epigenetic control, particularly in relation to the Xp
arm of the inactive X chromosome, as being of signiﬁcance in the
mechanisms of autoimmune diseases.
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